Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen Wyne

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Managed Care & Specialty Pharmacy|August 30, 2018
Glycemic Efficacy, Weight Effects, and Safety of Once-Weekly Glucagon-Like Peptide-1 Receptor AgonistsYehuda Handelsman, Kathleen Wyne, Anthony Cannon, et al.
Journal of Managed Care & Specialty Pharmacy|February 27, 2019
CorrectionsYehuda Handelsman, Kathleen Wyne, Anthony Cannon, et al.
Journal of Managed Care & Specialty Pharmacy|August 30, 2018
Health-Related Quality of Life Assessments with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes MellitusLiana K Billings, Yehuda Handelsman, Michael Heile, et al.
Current Medical Research and Opinion|June 8, 2018
Adherence to thyroid hormone replacement therapy: a retrospective, claims database analysisZsolt Hepp, Kathleen Wyne, Shivaji R Manthena, et al.
Journal of Community Health|February 8, 2023
Applying National Diabetic Care Standards for the Management of a Hispanic Population Attending a Free ClinicEmily Lawson, Vamsee Vemulapalli, Anthony Barnes, et al.
Advances in Therapy|April 1, 2019
Differentiating Basal Insulin Preparations: Understanding How They Work Explains Why They Are DifferentAlice Y Y Cheng, Dhiren K Patel, Timothy S Reid, et al.
Therapeutics and Clinical Risk Management|March 28, 2014
Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitusKatia Cristina Portero McLellan, Kathleen Wyne, Evangelina Trejo Villagomez, et al.
Journal of Managed Care & Specialty Pharmacy|August 30, 2018
Cardiovascular Outcomes with Once-Weekly GLP-1 RAs: Clinical and Economic ImplicationsMichael Heile, Kathleen Wyne, Liana K Billings, et al.
Journal of Investigative Medicine High Impact Case Reports|July 28, 2017
The Yin and Yang Between Plasma Glucose Levels and Cortisol Replacement Therapy in Schmidt's SyndromeChristopher A Newton, Eleni Sheehan, Kathleen Wyne, et al.
The Annals of Pharmacotherapy|June 10, 2022
The Impact of a Diabetes Transitions of Care Clinic on Hospital Utilization and Patient CareAlyssa Rinaldi, Melissa Snider, Amy James, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Managed Care & Specialty Pharmacy|August 30, 2018
Glycemic Efficacy, Weight Effects, and Safety of Once-Weekly Glucagon-Like Peptide-1 Receptor AgonistsYehuda Handelsman, Kathleen Wyne, Anthony Cannon, et al.
Journal of Managed Care & Specialty Pharmacy|February 27, 2019
CorrectionsYehuda Handelsman, Kathleen Wyne, Anthony Cannon, et al.
Journal of Managed Care & Specialty Pharmacy|August 30, 2018
Health-Related Quality of Life Assessments with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes MellitusLiana K Billings, Yehuda Handelsman, Michael Heile, et al.
Current Medical Research and Opinion|June 8, 2018
Adherence to thyroid hormone replacement therapy: a retrospective, claims database analysisZsolt Hepp, Kathleen Wyne, Shivaji R Manthena, et al.
Journal of Community Health|February 8, 2023
Applying National Diabetic Care Standards for the Management of a Hispanic Population Attending a Free ClinicEmily Lawson, Vamsee Vemulapalli, Anthony Barnes, et al.
Advances in Therapy|April 1, 2019
Differentiating Basal Insulin Preparations: Understanding How They Work Explains Why They Are DifferentAlice Y Y Cheng, Dhiren K Patel, Timothy S Reid, et al.
Therapeutics and Clinical Risk Management|March 28, 2014
Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitusKatia Cristina Portero McLellan, Kathleen Wyne, Evangelina Trejo Villagomez, et al.
Journal of Managed Care & Specialty Pharmacy|August 30, 2018
Cardiovascular Outcomes with Once-Weekly GLP-1 RAs: Clinical and Economic ImplicationsMichael Heile, Kathleen Wyne, Liana K Billings, et al.
Journal of Investigative Medicine High Impact Case Reports|July 28, 2017
The Yin and Yang Between Plasma Glucose Levels and Cortisol Replacement Therapy in Schmidt's SyndromeChristopher A Newton, Eleni Sheehan, Kathleen Wyne, et al.
The Annals of Pharmacotherapy|June 10, 2022
The Impact of a Diabetes Transitions of Care Clinic on Hospital Utilization and Patient CareAlyssa Rinaldi, Melissa Snider, Amy James, et al.
Pageof 4